N-SIDE announces new partnership with BeiGene

N-SIDE, a deeptech company that empowers life sciences organizations to make better decisions and optimize the use of critical resources, is pleased to announce our new growing partnership with BeiGene. BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide.

BeiGene and N-SIDE started their collaboration using the N-SIDE solutions to streamline BeiGene’s clinical trial supply chain following the signature of a 3-year contract. This new partnership is perfectly aligned with N-SIDE’s growth strategy in Asia. The N-SIDE solutions combines deep clinical supply chain expertise with advanced mathematics packaged into an easy to use and cutting-edge solution.

Following the fast growth of biotech companies leveraging AI and data to reduce their clinical development timelines, N-SIDE provides the technology to enable more efficient R&D decisions and activities.

“We’ve contributed to the trend of lightspeed projects delivering urgent medicines to patients in need in a faster way. Aligning clinical organizations with the right business processes and technology is a key strategic objective for all biotech companies nowadays.” - Sébastien Coppe, Life Sciences Director

Learn how the N-SIDE solutions can help you accelerate plans, mitigate risks and curb drug waste.